Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. John A. Orwin$6.7M
Market Cap • 18/03/20242010
(há 14 anos)
NASDAQ
Listagem
San Carlos
Sede • California90
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BCELSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.